SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-20-072903
Filing Date
2020-03-13
Accepted
2020-03-13 16:15:56
Documents
1
Group Members
LSP V MANAGEMENT B.V.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d859421dsc13da.htm SC 13D/A 48082
  Complete submission text file 0001193125-20-072903.txt   49859
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Subject) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-56243 | Film No.: 20712887
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address JOHANNES VERMEERPLEIN 9 AMSTERDAM P7 1071 DV
Business Address JOHANNES VERMEERPLEIN 9 AMSTERDAM P7 1071 DV 31-20-664-5500
LSP V Cooperatieve U.A. (Filed by) CIK: 0001726006 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7
Type: SC 13D/A